Influenza Pathogenesis in Genetically Defined Resistant and Susceptible Murine Strains
- PMID: 28955185
- PMCID: PMC5612189
Influenza Pathogenesis in Genetically Defined Resistant and Susceptible Murine Strains
Abstract
The murine infection model is a cornerstone for influenza virus research and includes aspects such as disease pathogenesis, immunobiology, and vaccine and antiviral drug development. One compelling feature of the murine model is the availability of inbred mouse strains, each with a unique genetic makeup and potential for variable responses to influenza infection. Using highly controlled infection studies, the response to influenza virus infection is classified on a spectrum from susceptible to resistant, reflecting severe morbidity and high mortality, to limited or no morbidity and no mortality. Although there have been a variety of studies establishing disparate pathogenesis amongst various murine strains, thus far, there is no consensus regarding the determinants of the outcome of infection. The goal of this review is to explore and discuss the differences in pathogenesis, as well as the innate and adaptive immune responses to influenza infection that have been described in susceptible and resistant mouse strains. Understanding how host genetics influences the response to influenza infection provides valuable insight into the variable responses seen in vaccine or drug efficacy studies, as well as indicates possible mechanisms contributing to increased disease severity in humans infected with influenza virus with no known risk factors.
Keywords: Influenza virus; immunology; murine strains; susceptibility.
Similar articles
-
Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.mBio. 2015 Oct 27;6(6):e01024-15. doi: 10.1128/mBio.01024-15. mBio. 2015. PMID: 26507227 Free PMC article.
-
MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.J Virol. 2018 Jan 2;92(2):e01741-17. doi: 10.1128/JVI.01741-17. Print 2018 Jan 15. J Virol. 2018. PMID: 29093096 Free PMC article.
-
Mouse Saliva Inhibits Transit of Influenza Virus to the Lower Respiratory Tract by Efficiently Blocking Influenza Virus Neuraminidase Activity.J Virol. 2017 Jun 26;91(14):e00145-17. doi: 10.1128/JVI.00145-17. Print 2017 Jul 15. J Virol. 2017. PMID: 28446666 Free PMC article.
-
Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.Scand J Immunol. 2004 Jan;59(1):1-15. doi: 10.1111/j.0300-9475.2004.01382.x. Scand J Immunol. 2004. PMID: 14723616 Review.
-
Studies on the usefulness of intranasal inactivated influenza vaccines.Vaccine. 2010 Aug 31;28(38):6393-7. doi: 10.1016/j.vaccine.2010.05.019. Epub 2010 May 20. Vaccine. 2010. PMID: 20493820 Review.
Cited by
-
Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.J Virol. 2020 Nov 9;94(23):e01185-20. doi: 10.1128/JVI.01185-20. Print 2020 Nov 9. J Virol. 2020. PMID: 32907980 Free PMC article.
-
Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway.Eur J Immunol. 2021 May;51(5):1039-1061. doi: 10.1002/eji.202048793. Epub 2021 Apr 4. Eur J Immunol. 2021. PMID: 33729549 Free PMC article. Review.
-
Bayesian Diallel Analysis Reveals Mx1-Dependent and Mx1-Independent Effects on Response to Influenza A Virus in Mice.G3 (Bethesda). 2018 Feb 2;8(2):427-445. doi: 10.1534/g3.117.300438. G3 (Bethesda). 2018. PMID: 29187420 Free PMC article.
-
Preventative treatment with Fluorothiazinon suppressed Acinetobacter baumannii-associated septicemia in mice.J Antibiot (Tokyo). 2022 Mar;75(3):155-163. doi: 10.1038/s41429-022-00504-y. Epub 2022 Jan 21. J Antibiot (Tokyo). 2022. PMID: 35064243 Free PMC article.
-
Pandemic Risk Assessment for Swine Influenza A Virus in Comparative In Vitro and In Vivo Models.Viruses. 2024 Mar 31;16(4):548. doi: 10.3390/v16040548. Viruses. 2024. PMID: 38675891 Free PMC article.
References
-
- Organization WH. Influenza (seasonal) fact sheet N211. 2014.
-
- Centers for Disease C Prevention. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices—United States, 2013-2014. MMWR Recomm Rep. 2013;62 RR-07:1–43. - PubMed
-
- Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112(6):798–811. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical